CHAPEL HILL, N.C., Jan. 31 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a
pharmaceutical development company with a portfolio of product candidates for
the treatment of migraine, announced that John R. Plachetka, Pharm. D., the
company's chairman, president and chief executive officer, will make a
presentation to investors and financial analysts during the U.S. Bancorp. Piper Jaffray
Health Care Conference on Thursday, February 1, 2001, at 9:30 a.m. EST. A
live webcast will be accessible through the following link:
http://www.gotoanalysts.com/healthcareconference
North Carolina-based POZEN Inc. is a pharmaceutical development company
committed to building a portfolio of products with significant commercial
potential in select therapeutic areas. The company's initial focus is
migraine, where it has built a robust portfolio of four product candidates
through a combination of innovation and in-licensing. The company's common
stock is traded on The Nasdaq Stock Market under the symbol "POZN."
POZEN is on the Internet at http://www.pozen.com .
CONTACT:
Matthew E. Czajkowski
Chief Financial Officer of Pozen
919-490-0012
or
General Inquiries
Marilyn Windsor of The Financial Relations
Board
312-640-6692
